Asahi Intecc Reports Strong Sales Growth Amid Challenges

Asahi Intecc Co ( (AHICF) ) has released its Q3 earnings. Here is a breakdown of the information Asahi Intecc Co presented to its investors.

Asahi Intecc Co., Ltd. is a Japanese company listed on the Tokyo and Nagoya Stock Exchanges, specializing in the medical device sector with a focus on developing and manufacturing products for the cardiovascular and non-cardiovascular fields. The company is known for its innovative approach and global market presence.

In its latest earnings report for the nine months ending March 31, 2025, Asahi Intecc reported a significant increase in net sales and operating profit, driven by strong performance in its Medical Division both domestically and internationally. However, the company saw a decline in profit attributable to owners of the parent due to extraordinary losses, including impairment losses.

Key financial highlights include a 13.7% increase in net sales to 91,815 million yen and a 30.8% rise in operating profit to 25,715 million yen. The Medical Division saw robust growth with net sales rising by 15.5%, while the Device Division experienced a slight decline in net sales. Despite these gains, profit attributable to owners of the parent decreased by 37.6% to 8,763 million yen, largely due to recorded impairment losses.

Looking ahead, Asahi Intecc has revised its full-year financial forecast, anticipating continued growth in net sales and operating profit, supported by its strategic initiatives and market expansion efforts. The company remains committed to enhancing its corporate value through its medium-term management plan, “ASAHI Going Beyond 1000.”